Seegene announces collaboration with microsoft to realize 'a world free from all diseases'

Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics' digitally enhance seegene's automated diagnostic reagent development system with the integration of microsoft azure ai solutions a declaration ceremony within 1h 2024 to launch the unified vision seoul, south korea, jan. 24, 2024 /prnewswire/ -- seegene inc. (kq096530), a leading south korean company providing a total solution for pcr molecular diagnostics, announced its selection of microsoft as a technology partner for its sg onesystemtm business in london, uk, on january 23 to realize 'a world free from all diseases.' seegene will collaborate with microsoft to help propel the growth of its sg onesystemtm business, an unprecedented strategy by seegene to share its unique syndromic quantitative pcr technologies with leading companies across the world to drive cross-industry innovation in molecular diagnostics.
MSFT Ratings Summary
MSFT Quant Ranking